Similarly, the levels of neutralizing anti-SARS-CoV-2 S IgG and IgA antibodies did not correlate with the age of patients who had recovered from mild disease, even though convalescent patients with severe disease were on average older than those with mild COVID-19 (Fig. S5). The gene discussed is CD79A; the disease is COVID-19.